Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J Everly

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Transplantation|May 23, 2009
Abrogation of anti-HLA antibodies via proteasome inhibitionHargovind L Trivedi, Paul I Terasaki, Aziz Feroz, et al.
Transplantation|February 6, 2013
Incidence and impact of de novo donor-specific alloantibody in primary renal allograftsMatthew J Everly, Lorita M Rebellato, Carl E Haisch, et al.
Transplantation|December 5, 2015
HLA and Risk of Diffuse Large B cell Lymphoma After Solid Organ TransplantationShehnaz K Hussain, Solomon B Makgoeng, Matthew J Everly, et al.
Transplantation|December 24, 2008
Bortezomib provides effective therapy for antibody- and cell-mediated acute rejectionMatthew J Everly, Jason J Everly, Brian Susskind, et al.
The Journal of Clinical Investigation|July 23, 2019
Antibiotic pretreatment alleviates liver transplant damage in mice and humansKojiro Nakamura, Shoichi Kageyama, Takahiro Ito, et al.
Diabetes|January 1, 2013
Alloantibody and autoantibody monitoring predicts islet transplantation outcome in human type 1 diabetesLorenzo Piemonti, Matthew J Everly, Paola Maffi, et al.
Transplantation|April 26, 2021
The Role of Patient-reported Outcomes and Medication Adherence Assessment in Patient-focused Drug Development for Solid Organ TransplantationStephen R Karpen, Amanda Klein, Rita R Alloway, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 15, 2018
The importance of drug safety and tolerability in the development of new immunosuppressive therapy for transplant recipients: The Transplant Therapeutics Consortium's position statementMark D Stegall, Kenneth Troy Somerville, Matthew J Everly, et al.
Journal of the American Society of Nephrology : JASN|March 2, 2013
The clinical impact of humoral immunity in pediatric renal transplantationAbanti Chaudhuri, Mikki Ozawa, Matthew J Everly, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Transplantation|May 23, 2009
Abrogation of anti-HLA antibodies via proteasome inhibitionHargovind L Trivedi, Paul I Terasaki, Aziz Feroz, et al.
Transplantation|February 6, 2013
Incidence and impact of de novo donor-specific alloantibody in primary renal allograftsMatthew J Everly, Lorita M Rebellato, Carl E Haisch, et al.
Transplantation|December 5, 2015
HLA and Risk of Diffuse Large B cell Lymphoma After Solid Organ TransplantationShehnaz K Hussain, Solomon B Makgoeng, Matthew J Everly, et al.
Transplantation|December 24, 2008
Bortezomib provides effective therapy for antibody- and cell-mediated acute rejectionMatthew J Everly, Jason J Everly, Brian Susskind, et al.
The Journal of Clinical Investigation|July 23, 2019
Antibiotic pretreatment alleviates liver transplant damage in mice and humansKojiro Nakamura, Shoichi Kageyama, Takahiro Ito, et al.
Diabetes|January 1, 2013
Alloantibody and autoantibody monitoring predicts islet transplantation outcome in human type 1 diabetesLorenzo Piemonti, Matthew J Everly, Paola Maffi, et al.
Transplantation|April 26, 2021
The Role of Patient-reported Outcomes and Medication Adherence Assessment in Patient-focused Drug Development for Solid Organ TransplantationStephen R Karpen, Amanda Klein, Rita R Alloway, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 15, 2018
The importance of drug safety and tolerability in the development of new immunosuppressive therapy for transplant recipients: The Transplant Therapeutics Consortium's position statementMark D Stegall, Kenneth Troy Somerville, Matthew J Everly, et al.
Journal of the American Society of Nephrology : JASN|March 2, 2013
The clinical impact of humoral immunity in pediatric renal transplantationAbanti Chaudhuri, Mikki Ozawa, Matthew J Everly, et al.
Pageof 7